188 related articles for article (PubMed ID: 15716381)
1. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins.
Short SM; Derrien A; Narsimhan RP; Lawler J; Ingber DE; Zetter BR
J Cell Biol; 2005 Feb; 168(4):643-53. PubMed ID: 15716381
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism.
Cattaneo MG; Lucci G; Vicentini LM
Exp Cell Res; 2009 Nov; 315(18):3210-9. PubMed ID: 19563802
[TBL] [Abstract][Full Text] [Related]
3. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor.
Kaneko Y; Kitazato K; Basaki Y
J Cell Sci; 2004 Jan; 117(Pt 3):407-15. PubMed ID: 14679308
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.
Chu LY; Ramakrishnan DP; Silverstein RL
Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD36 molecular features required for its in vitro angiostatic activity.
Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
[TBL] [Abstract][Full Text] [Related]
6. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.
Kazerounian S; Duquette M; Reyes MA; Lawler JT; Song K; Perruzzi C; Primo L; Khosravi-Far R; Bussolino F; Rabinovitz I; Lawler J
Blood; 2011 Apr; 117(17):4658-66. PubMed ID: 21378271
[TBL] [Abstract][Full Text] [Related]
7. CD98 modulates integrin beta1 function in polarized epithelial cells.
Cai S; Bulus N; Fonseca-Siesser PM; Chen D; Hanks SK; Pozzi A; Zent R
J Cell Sci; 2005 Mar; 118(Pt 5):889-99. PubMed ID: 15713750
[TBL] [Abstract][Full Text] [Related]
8. PI3-kinase p110α mediates β1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading.
Zeller KS; Idevall-Hagren O; Stefansson A; Velling T; Jackson SP; Downward J; Tengholm A; Johansson S
Cell Signal; 2010 Dec; 22(12):1838-48. PubMed ID: 20667469
[TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
[TBL] [Abstract][Full Text] [Related]
11. Cellular repressor of E1A-stimulated genes regulates vascular endothelial cell migration by the ILK/AKT/mTOR/VEGF(165) signaling pathway.
Zhang H; Han Y; Tao J; Liu S; Yan C; Li S
Exp Cell Res; 2011 Dec; 317(20):2904-13. PubMed ID: 21939655
[TBL] [Abstract][Full Text] [Related]
12. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36.
Klenotic PA; Page RC; Li W; Amick J; Misra S; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1655-62. PubMed ID: 23640500
[TBL] [Abstract][Full Text] [Related]
14. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.
Knight EL; Warner AJ; Maxwell A; Prigent SA
Oncogene; 2000 Nov; 19(47):5398-405. PubMed ID: 11103941
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles Activate a CD36-Dependent Signaling Pathway to Inhibit Microvascular Endothelial Cell Migration and Tube Formation.
Ramakrishnan DP; Hajj-Ali RA; Chen Y; Silverstein RL
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):534-44. PubMed ID: 26821945
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
17. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
18. Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling.
Sun P; Wang XQ; Lopatka K; Bangash S; Paller AS
J Invest Dermatol; 2002 Jul; 119(1):107-17. PubMed ID: 12164932
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia-induced fibronectin-integrin β1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK.
Lee SH; Lee YJ; Han HJ
J Cell Physiol; 2011 Feb; 226(2):484-93. PubMed ID: 20677223
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells.
Montiel M; de la Blanca EP; Jiménez E
Biochem Biophys Res Commun; 2005 Feb; 327(4):971-8. PubMed ID: 15652490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
